Clinical Trials
2 trialsNCT06080776 2023-10-12
SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 3 Recruiting
NCT04239833 2020-01-27
A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 3 Unknown